TrialAnnals of hematology2021

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.

Won Seog Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.